New visitor? Consider subscribing by RSS or by email.A few news items worth mentioning:
Advocat, Inc. [[AVCA]] received a letter from activist shareholder Paul Kessler of Bristol Investment Fund pressuring it, among other things, to let shareholders vote on whether to de-stagger the board of directors and to [...]
China Pharma Holdings (CPHI.OB) has come a long way since I purchased the stock and profiled it in early August. In less than three months, shares rose from around $1.40 to over $3.75, although they gave up almost 10% by the close today. Curiously, only a part of the runup appears to be related [...]
After the bell, China Pharma Holdings: CPHI.OB filed impressive quarterly results with the SEC. The company, which I profiled in greater detail a few weeks ago, announced quarterly earnings of approximately $3.33M, or $.09 per fully-diluted share, on revenues of $8.57M. All metrics improved over the same quarter in 2006, when the company [...]
Microcap traders have hit homeruns in a number of Chinese pharmaceutical and biotech companies, such as American Oriental Bioengineering (AOB) and Tiens Biotech (TBV). Reader J.Z. has alerted me to another intriguing Chinese pharmaceutical play — China Pharma Holdings: CPHI.OB. China Pharma develops, manufactures, and markets Chinese and Western bio-pharmaceutical products for treating [...]